Alendronic acid and Loraz drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Alendronic acid (alendronate sodium) and Loraz (lorazepam). Common drug interactions include deep vein thrombosis postoperative among females and constipation among males.
The phase IV clinical study analyzes what interactions people have when they take Alendronic acid and Loraz. It is created by eHealthMe based on reports of 900 people who take the same drugs from the FDA, and is updated regularly.
What is Alendronic acid?
Alendronic acid has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 18,408 Alendronic acid users. Check the latest studies of Alendronic acid.
What is Loraz?
Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.
900 people who take Alendronic acid and Loraz together, and have interactions are studied.
What are the common drug interactions of Alendronic acid and Loraz, by gender? *
What are the common drug interactions of Alendronic acid and Loraz, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Alendronic acid and Loraz?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Alendronic acid (18,408 reports)
- Loraz (165,695 reports)
Browse all drug interactions of Alendronic acid and Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alendronic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Alendronic acid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Loraz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium and lorazepam (the active ingredients of Alendronic acid and Loraz, respectively), and Alendronic acid and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lamotrigine and Northera - 13 seconds ago
- Drug interactions of Sudafed and Xeljanz Xr - 29 seconds ago
- Paracetamol and Interstitial Nephritis for Women aged 40-49 - 29 seconds ago
- Paracetamol and Nephritis - Interstitial for Women aged 40-49 - 29 seconds ago
- Paracetamol and Acute Interstitial (Allergic) Nephritis for Women aged 40-49 - 30 seconds ago
- Paracetamol and Tubulointerstitial Nephritis for Women aged 40-49 - 30 seconds ago
- Drug interactions of Suboxone and Ferrous Fumarate - 43 seconds ago
- Bupivacaine Hydrochloride and Drug Intolerance for Women aged 40-49 - 58 seconds ago
- Medrol and Gravitational Oedema for Women aged 60+ - a minute ago
- Drug interactions of Depakote and Xcopri - a minute ago